期刊文献+

不稳定心绞痛患者肾动脉狭窄危险因素临床分析

暂未订购
导出
摘要 目的探讨不稳定心绞痛患者中动脉粥样硬化性肾动脉狭窄(ARAS)的患病率及其危险因素。方法123例不稳定心绞痛患者冠脉造影同时行选择性双肾动脉造影检查,对临床资料和ARAS之间的关系进行单因素和多因素Logistic回归分析。结果123例不稳定心绞痛患者ARAS的发生率为22.8%;单因素分析表明,年龄、高血压、高血脂、糖尿病、吸烟、肾功能不全、颈动脉粥样斑块是ARAS的预测因素。多元Logistic回归分析表明,年龄、颈动脉粥样斑块、冠脉三支病变是ARAS的独立预测因素。结论对不稳定心绞痛患者特别是冠脉三支病变者,尤其伴有高龄、颈动脉粥样斑块者,应该在冠脉造影后行肾动脉造影检查,以便及早发现ARAS。
出处 《心脑血管病防治》 2009年第6期445-447,共3页 CARDIO-CEREBROVASCULAR DISEASE PREVENTION AND TREATMENT
  • 相关文献

参考文献10

  • 1Voiculescu A, Grabensee B, Jung G, et al. Renovascular disease: a review of diagnostic and therapeutic procedures [ J ]. Minerva Urol Nefrol, 2006: 58 : 127 - 149.
  • 2Park S, Jung JH, Seo HS. The prevalence and clinical predictors of atherosclerotic rental artery stenosis in patients undergoing coronary angiography[J]. Heart Vessels,2004, 19:275 - 279.
  • 3Wright JR, Shurrab AE, Cheung c, et al. A prospective study of the determinants of renal functional outcome and morality in atherosclerotic renovascular disease[J]. Am J Kidney Dis,2002,39(6) : 1153 - 1161.
  • 4Hostetter TH. Chronic kidney disease predicts cardiovascular disease[J]. N Engl J Med,2004,351(13) : 1344- 1346.
  • 5Iwanage Y, Kihara Y, Inagaki K, et al. Differential efects of angiotensin Ⅱ versus endiothelin-1 inhi-bitions in hypertrophic left myocardium during transition to heart failure[J]. Circulation,2001 (6):602- 612.
  • 6李世军,李小鹰.肾动脉狭窄的流行病学与诊断策略最新进展[J].中华老年心脑血管病杂志,2007,9(5):354-355. 被引量:7
  • 7杨进刚,胡大一,刘坤申,李田昌,彭建军,商丽华.冠状动脉造影患者中肾动脉狭窄的发生率[J].中华内科杂志,2002,41(1):24-27. 被引量:48
  • 8Crowley J J, Santos RM, Peter RH, et al. Progression of renal artery stenosis in patients undergoing cardiac catheterization[J]. Am Heart J, 1998,136:913 - 918.
  • 9顾勇.充分认识和重视动脉粥样硬化性肾动脉狭窄[J].中华肾脏病杂志,2006,22(6):317-318. 被引量:7
  • 10陈步星,孙淑红,马风云,罗维,高光敏,赵希哲,王枫.冠状动脉造影患者中高血压合并肾动脉狭窄发生率及其影响因素[J].心肺血管病杂志,2005,24(3):136-138. 被引量:7

二级参考文献36

  • 1胡大一 李田昌 等.心脏及血管疾病的现代治疗[J].中国医药导刊,2000,9:73-76.
  • 2杨进刚.RAS的血管成形技术[J].中国医药导刊,2000,(2):148-148.
  • 3Harding MB, Smith LR, Himmelstein SI, et al. Renal artery stenosis: prevalence and associated risk factors in patients undergoing routine cardiac catheterization. J Am Soc Nephrol, 1992, 2:1608-1616.
  • 4Conlon PJ, O′Riordan E, Kalra PA. New insights into the epidemiologic and clinical manifestations of atherosclerotic renovascular disease. Am J Kidney Dis, 2000, 35:573-587.
  • 5Missouris CG, Buckenham T, Vallance PJ, et al. Renal artery stenosis masquerading as congestive heart failure. Lancet, 1993, 341:1521-1522.
  • 6Wilson PW, Hoeg JM, D′Agostino RB, et al.Cumulative effects of high cholesterol levels, high blood pressure, and cigarette smoking on carotid stenosis.N Engl J Med, 1997, 337:516-522.
  • 7Farmer CK, Cook GJ, Blake GM, et al. Individual kidney function in atherosclerotic nephropathy is not related to the presence of renal artery stenosis.Nephrol Dial Transplant, 1999, 14:2880-2884.
  • 8Textor SC. Revascularization in atherosclerotic renal artery disease. Kidney Int, 1998, 53:799-811.
  • 9McLaughlin K, Jardine AG, Moss JG. ABC of arterial and venous disease. Renal artery stenosis. BMJ, 2000, 320:1124-1127.
  • 10Woolfson RG, Lachmann H. Improvement in renal cholesterol emboli syndrome after simvastatin. Lancet, 1998,351:1331-1332.

共引文献64

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部